Delivery Order SPE2DB22D2108-SPE2DB25FU5LB
- Not listed
- The Defense Logistics Agency awarded a $1,883.70 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Eliquis 2.5 mg tablets (60-count). This firm fixed-price contract is non-set-aside and scheduled for completion by July 24, 2025, with performance taking place at the contractor's headquarters in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with the agency. This award...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on July 29, 2025, with completion targeted for July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $5,514.22 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 5, 2025, with completion scheduled for August 6, 2025. This competitive award, issued on a firm fixed-price basis with no set-aside designation, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $3,271.68 with a firm fixed price structure and an ultimate completion date of August 12, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999.999 billion and...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Eliquis 2.5 mg tablets in quantities of 60 units. This non-competitive, firm fixed-price delivery order is set to be completed by August 11, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order issued under AmerisourceBergen's broader pharmaceutical supply agreements with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages). This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a $2,214.72 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price contract with a completion date of August 14, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation. Performance will occur at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count) valued at $14,097.60. This firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5LBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on August 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medical commodities including brand-name and generic medications, vaccines, and specialized healthcare products to support Defense Health Agency operations and other federal healthcare programs. The rapid fulfillment timeline reflects the time-sensitive nature of pharmaceutical procurement for military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/13/25 |